DKSH will utilize its market expansion expertise to introduce Countstarโs innovative cell analysis systems into Malaysia, driving growth in the life sciences and biopharma sectors with cutting-edge technology and comprehensive distribution services.
Petaling Jaya, Malaysia, December 20, 2024 โ DKSH Business Unit Technology has formed a partnership with Countstar, a leading cell analysis solutions provider, in Malaysia. The partnership aims to expand access to Countstarโs cutting-edge cell analysis systems in Malaysia, with a focus on life sciences, biotech, and pharmaceutical sectors. This agreement marks Countstarโs entry into the Malaysian market, leveraging DKSHโs extensive distribution and market expansion services to establish a strong presence.
Founded by ALIT Biotech, Countstar is a pioneer in developing innovative equipment and consumables for biological research. With its advanced combination of bright-field and fluorescent imaging technologies, Countstarโs cell analysis systems provide comprehensive real-time data on cell morphology, viability, and concentration. The systems have become invaluable tools in research, process development, and production environments, with over 6,000 units installed worldwide. The end-users of these technologies include academic life science labs, government agencies, and major players in the biotech, pharma, and biopharma industries.
Through this exclusive agreement, DKSH will distribute Countstarโs Mira line of cell counters and provide marketing, sales, application services, and full after-sales support. The partnership will open new opportunities for Malaysian life sciences researchers and professionals, offering them access to state-of-the-art analytical equipment. Beyond the Mira line, DKSH will also offer other Countstar products, non-exclusively, as part of its commitment to deliver best-in-class solutions to its network.
Gavin Huang, Sales & Marketing Director at Countstar, expressed: โCountstar is excited to collaborate with DKSH to bring our innovative cell analysis systems to the Malaysian market. DKSHโs extensive knowledge of the local life sciences landscape and its strong distribution network will be invaluable in expanding our reach and helping us provide advanced solutions to researchers, scientists, and manufacturers in the region.โ
Marco Farina, Senior Director of Business Development and Center of Excellence at DKSH, remarked: โWe are thrilled to partner with Countstar to introduce their advanced cell analysis solutions to Malaysia. This collaboration aligns perfectly with our mission to bring innovative and world-class technologies to the market. Moreover, the demand for precise and efficient cell analysis tools is increasing, and with Countstarโs AI-driven innovation, we are confident that this partnership will drive growth for both companies.โ
About Countstar
Countstar is a brand of ALIT Biotech, a Shanghai-based company specializing in developing innovative cell analysis equipment for research and production environments. Countstar combines advanced imaging technologies with user-friendly interfaces to deliver real-time, high-resolution data for academic, biotech, and pharma labs worldwide. www.countstar.comย
About DKSH
DKSHโs purpose is to enrich peopleโs lives. For almost 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 29,040 specialists, generating net sales of CHF 11.1 billion in 2023. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,760 specialists, the Business Unit generated net sales of CHF 532.6 million in 2023. www.dksh.com/tec